DK0817852T3 - Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein - Google Patents

Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein

Info

Publication number
DK0817852T3
DK0817852T3 DK96912467T DK96912467T DK0817852T3 DK 0817852 T3 DK0817852 T3 DK 0817852T3 DK 96912467 T DK96912467 T DK 96912467T DK 96912467 T DK96912467 T DK 96912467T DK 0817852 T3 DK0817852 T3 DK 0817852T3
Authority
DK
Denmark
Prior art keywords
protein
human papillomavirus
synthetic
hpv6
hybrid
Prior art date
Application number
DK96912467T
Other languages
Danish (da)
English (en)
Inventor
Kathrin U Jansen
Hugh A George
Kathryn J Hofmann
Joseph G Joyce
Michael P Neeper
E Dale Lehman
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27022236&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0817852(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0817852T3 publication Critical patent/DK0817852T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
DK96912467T 1995-03-30 1996-03-26 Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein DK0817852T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US41357195A 1995-03-30 1995-03-30
US41357295A 1995-03-30 1995-03-30
PCT/US1996/004117 WO1996030520A2 (en) 1995-03-30 1996-03-26 Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein

Publications (1)

Publication Number Publication Date
DK0817852T3 true DK0817852T3 (da) 2003-11-24

Family

ID=27022236

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96912467T DK0817852T3 (da) 1995-03-30 1996-03-26 Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein

Country Status (21)

Country Link
US (1) US6159729A (no)
EP (1) EP0817852B1 (no)
JP (1) JP3918877B2 (no)
KR (1) KR100441477B1 (no)
CN (1) CN1154732C (no)
AT (1) ATE247712T1 (no)
AU (1) AU708111B2 (no)
CZ (1) CZ291375B6 (no)
DE (1) DE69629556T2 (no)
DK (1) DK0817852T3 (no)
EA (1) EA000969B1 (no)
ES (1) ES2203691T3 (no)
HU (1) HU228490B1 (no)
IL (1) IL117591A0 (no)
NO (1) NO320086B1 (no)
NZ (1) NZ306663A (no)
PL (1) PL183299B1 (no)
PT (1) PT817852E (no)
SK (1) SK283998B6 (no)
WO (1) WO1996030520A2 (no)
ZA (1) ZA962526B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0782615A4 (en) * 1994-09-22 2001-08-22 Merck & Co Inc DNA ENCODING FOR HUMAN PAPILLOMAVIRUS TYPE 6A
GB9621091D0 (en) 1996-10-09 1996-11-27 Fondation Pour Le Perfectionem Attenuated microorganisms strains and their uses
KR20010006169A (ko) * 1997-04-08 2001-01-26 폴락 돈나 엘. 안정화된 사람 파필로마바이러스 제형물
ES2262333T3 (es) * 1998-08-14 2006-11-16 MERCK & CO., INC. Procedimiento para purificar particulas similares a virus de papilomavirus humano.
DE19840263C1 (de) 1998-09-03 2000-05-25 Deutsches Krebsforsch Papillomviren, Mittel zu deren Nachweis sowie zur Therapie von durch sie verursachten Erkrankungen
US6380364B1 (en) 1998-11-23 2002-04-30 Loyola University Of Chicago Chimeric biotin-binding papillomavirus protein
AUPP765398A0 (en) * 1998-12-11 1999-01-14 University Of Queensland, The Treatment of papillomavirus infections
DK1150712T3 (da) 1999-02-05 2009-02-02 Merck & Co Inc Vaccineformuleringer mod human papillomavirus
US7001995B1 (en) * 1999-08-25 2006-02-21 Merck & Co., Inc. Synthetic human papillomavirus genes
SI1421200T1 (sl) * 2001-08-23 2007-04-30 Merck & Co Inc Poskusi PCR fluorescentnih multipleks HPV-jev z uporabo vec fluoroforov
EP1302550A1 (en) * 2001-10-10 2003-04-16 King Car Food Industrial Co., Ltd. Method and detector for identifying subtypes of human papilloma viruses
US20040223976A1 (en) * 2003-03-07 2004-11-11 Elisabetta Bianchi Influenza virus vaccine
EP1608767B1 (en) * 2003-03-24 2012-02-22 Merck Sharp & Dohme Corp. Optimized expression of hpv 31 l1 in yeast
IL156670A0 (en) * 2003-06-26 2004-01-04 Zvi Zolotariov Aloe suppositories
BRPI0414801A (pt) * 2003-09-25 2006-11-14 Third Wave Tech Inc detecção de hpv
MY140664A (en) * 2003-09-29 2010-01-15 Merck Sharp & Dohme Optimized expression of hpv 45 l1 in yeast
MY139500A (en) * 2003-11-12 2009-10-30 Merck Sharp & Dohme Optimized expression of hpv 58 l1 in yeast
ATE466022T1 (de) * 2004-03-24 2010-05-15 Merck Sharp & Dohme Optimierte expression von hpv-52-l1 in hefe
AU2005314061B2 (en) 2004-12-08 2010-01-28 Gen-Probe Incorporated Detection of nucleic acids from multiple types of human papillomaviruses
ES2524050T3 (es) * 2004-12-10 2014-12-03 Genera Biosystems Limited Detección del virus del papiloma humano (VPH) usando sondas de ácidos nucleicos, microperlas y clasificadores celulares activados por fluorescencia (FACS)
ATE474066T1 (de) * 2005-11-15 2010-07-15 Genoid Kft Verfahren zum nachweis von pathogenen mittels molecular beacons
US8080643B2 (en) * 2006-09-05 2011-12-20 Third Wave Technologies, Inc. HPV primers
CN101200696B (zh) * 2007-11-14 2011-07-20 山东大学 人乳头瘤病毒的酵母增殖模型及建立方法与应用
KR20090073987A (ko) * 2007-12-31 2009-07-03 정운원 인간유두종바이러스 유전자형 검사를 위한 프라이머, 프로브 및 이를 포함하는 ｄｎａ칩, 이의 검사 방법 및 검사 키트
EP2576840B1 (en) 2010-05-25 2018-10-17 QIAGEN Gaithersburg, Inc. Fast results hybrid capture assay and associated strategically-truncated probes
WO2012065034A1 (en) 2010-11-12 2012-05-18 Merck Sharp & Dohme Corp. Enolase peptide conjugate vaccines against staphylococcus aureus
EP2722389B1 (en) 2011-06-15 2018-03-07 Hong Jin Kim Method for enhancing the production yield of human papillomavirus l1 protein
KR20180084139A (ko) * 2015-12-04 2018-07-24 시아먼 유니버시티 11형 인유두종 바이러스 엘1 단백질의 돌연변이체
KR20210064318A (ko) * 2018-09-26 2021-06-02 시아먼 유니버시티 Hpv 타입 51의 l1 단백질의 돌연변이체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000018I1 (de) * 1991-07-19 2007-05-24 Univ Queensland Polynukleotidabschnitt des HPV16-Genoms
DE69435331D1 (de) * 1993-03-09 2011-02-03 Univ Rochester Herstellung von menschlichen papillomavirus HBV-11 Kapsidprotein L1 und Virus-ähnliche Partikeln

Also Published As

Publication number Publication date
SK129397A3 (en) 1998-05-06
DE69629556D1 (de) 2003-09-25
KR19980703391A (ko) 1998-10-15
HUP9801608A3 (en) 1999-04-28
HU228490B1 (en) 2013-03-28
DE69629556T2 (de) 2004-06-17
NZ306663A (en) 1999-10-28
EA000969B1 (ru) 2000-08-28
ES2203691T3 (es) 2004-04-16
CZ309197A3 (cs) 1998-02-18
WO1996030520A2 (en) 1996-10-03
AU5527796A (en) 1996-10-16
PL183299B1 (pl) 2002-06-28
US6159729A (en) 2000-12-12
ZA962526B (en) 1996-09-04
WO1996030520A3 (en) 1996-11-07
ATE247712T1 (de) 2003-09-15
CN1185810A (zh) 1998-06-24
EP0817852B1 (en) 2003-08-20
PL322588A1 (en) 1998-02-02
NO320086B1 (no) 2005-10-24
KR100441477B1 (ko) 2004-10-06
IL117591A0 (en) 1996-07-23
SK283998B6 (sk) 2004-07-07
CN1154732C (zh) 2004-06-23
NO974514D0 (no) 1997-09-29
PT817852E (pt) 2003-12-31
EA199700281A1 (ru) 1998-04-30
EP0817852A2 (en) 1998-01-14
AU708111B2 (en) 1999-07-29
JPH11503313A (ja) 1999-03-26
HUP9801608A2 (hu) 1998-10-28
JP3918877B2 (ja) 2007-05-23
CZ291375B6 (cs) 2003-02-12
NO974514L (no) 1997-11-27

Similar Documents

Publication Publication Date Title
DK0817852T3 (da) Syntetisk HPV6/11-hybrid-L1-DNA, der koder human papillomavirustype 11-L1-protein
NL300272I1 (nl) DNA dat humaan papillomavirus type 18 codeert.
NZ306009A (en) Medical database system, unique identifier assigned to files, machine readable version of identifier included in hard copies
AR038429A2 (es) Compuestos 15-alquil-16-hidroxilo de marcfortina
DE69519856T2 (de) Expression von albumin in hefe
BG101338A (en) Dna encoding human papillomavirus type 6a
IL122606A0 (en) (S)-hydroxy-nitrile-lyase
MX9707457A (es) Acido desoxirribonucleico sintetico hibrido l1 de hpv6/11 que codifica proteina l1 de virus de papiloma humano tipo 11.
ES2097368T3 (es) Nuevas proteinas inhibidoras de trombina a partir de sanguijuelas terrestres.
ATE267209T1 (de) Reinigung von carboxaldehyd
SE9501512D0 (sv) Synthetic peptide-defined eptopes useful for vaccination against papillomavirus
DK0891322T3 (da) Dimethylsubstituerede cyclohexandienderivater
ATE328088T1 (de) Transketolase-verwandtes protein
CA2216827A1 (en) Synthetic hpv6/11 hybrid l1 dna encoding human papillomavirus type 11 l1 protein
ES2191785T3 (es) Proteina de accion antitumoral.
NO982151D0 (no) Hemoregulatoriske forbindelser
BR9705217C2 (pt) Registro de datas em seis digitos até 31/c/z99.